Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.
King LDW. et al, (2024), Cell reports. Medicine, 5
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection
Hou MM. et al, (2023), Science Translational Medicine, 15
Functional Characterization and Comparison of Plasmodium falciparum Proteins as Targets of Transmission-blocking Antibodies
Nikolaeva D. et al, (2020), Molecular & Cellular Proteomics, 19, 155 - 166
Functional Characterization and Comparison of Plasmodium falciparum Proteins as Targets of Transmission-blocking Antibodies.
Nikolaeva D. et al, (2020), Molecular & cellular proteomics : MCP, 19, 155 - 166
DEMONSTRATION OF A BLOOD-STAGE CONTROLLED HUMAN MALARIA INFECTION MODEL FOR PLASMODIUM VIVAX VACCINE EFFICACY TESTING
Minassian AM. et al, (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 101, 133 - 134
Production and characterisation of the first human monoclonal antibodies against Plasmodium falciparum transmission blocking antigen Pfs25
Zaric M. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1683 - 1684
Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model
Yoshida K. et al, (2018), Scientific Reports, 8
Role of Activins in Hepcidin Regulation during Malaria
Spottiswoode N. et al, (2017), Infection and Immunity, 85
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
Payne RO. et al, (2017), JCI Insight, 2
Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal ‘C-tag’
Jin J. et al, (2017), International Journal for Parasitology, 47, 435 - 446
ENHANCED PROTECTIVE EFFICACY OF A PLASMODIUM FALCIPARUM MALARIA VACCINE USING A HETEROLOGOUS PRIME-BOOST IMMUNIZATION WITH A BACULOVIRAL VACCINE AND CHAD63 EXPRESSING PFCSP AGAINST CHALLENGE WITH TRANSGENIC P. BERGHEI SPOROZOITES
Yoshida K. et al, (2017), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 95, 314 - 314
Demonstration of the Blood-StagePlasmodium falciparumControlled Human Malaria Infection Model to Assess Efficacy of theP. falciparumApical Membrane Antigen 1 Vaccine, FMP2.1/AS01
Payne RO. et al, (2016), Journal of Infectious Diseases, 213, 1743 - 1751
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
Brune KD. et al, (2016), Scientific Reports, 6
Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology
Li Y. et al, (2016), Scientific Reports, 6
Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
Ewer KJ. et al, (2015), Vaccine, 33, 7444 - 7451
Recent advances in recombinant protein-based malaria vaccines
Draper SJ. et al, (2015), Vaccine, 33, 7433 - 7443
Comparative Assessment of Transmission-Blocking Vaccine Candidates against Plasmodium falciparum
Kapulu MC. et al, (2015), Scientific Reports, 5